{"id":206432,"date":"2021-11-18T11:11:38","date_gmt":"2021-11-18T14:11:38","guid":{"rendered":"https:\/\/www.suno.com.br\/noticias\/?p=206432"},"modified":"2021-11-18T11:11:38","modified_gmt":"2021-11-18T14:11:38","slug":"hypera-hype3-venda-eurofarma","status":"publish","type":"post","link":"https:\/\/www.suno.com.br\/noticias\/hypera-hype3-venda-eurofarma\/","title":{"rendered":"Hypera (HYPE3) vende portf\u00f3lio de medicamentos para a Eurofarma, por US$ 51 milh\u00f5es"},"content":{"rendered":"<p>A <a class=\"suno-keyword\" href=\"https:\/\/www.suno.com.br\/acoes\/HYPE3\/\" target=\"_blank\" rel=\"noopener\" data-force=\"yes\" data-priority=\"2\"><strong>Hypera<\/strong> (HYPE3)<\/a> fechou contrato com a Eurofarma para a venda do portf\u00f3lio de produtos farmac\u00eauticos isentos de prescri\u00e7\u00e3o m\u00e9dica, ou seja, de venda livre, e tamb\u00e9m dos que exigem o pedido m\u00e9dico na Col\u00f4mbia e no M\u00e9xico. O valor total da opera\u00e7\u00e3o ser\u00e1 de US$ 51,6 milh\u00f5es.<\/p>\t<div class=\"wrapper-featured-image\">\n\t\t<figure class=\"spotlightImg\">\n\n\t\t\t<picture>\n\t\t\t\t<source media=\"(max-width: 768px)\" srcset=\"https:\/\/files.sunoresearch.com.br\/n\/uploads\/2021\/03\/a651c83b-hypera.jpg-400x200.webp\">\n\t\t\t\t<img loading=\"lazy\" decoding=\"async\" class=\"newsContent__article__imgCapa lazyloadDisabled \" src=\"https:\/\/files.sunoresearch.com.br\/n\/uploads\/2021\/03\/a651c83b-hypera.jpg-800x450.webp\" width=\"800\" height=\"450\" alt=\"Hypera (HYPE3) vende portf\u00f3lio de medicamentos para a Eurofarma, por US$ 51 milh\u00f5es\" fetchpriority=high \/>\n\t\t\t<\/picture>\n\n\t\t\t<figcaption class=\"wp-caption-text wp-caption-text--show\">Hypera (HYPE3). Foto Divulga\u00e7\u00e3o<\/figcaption>\n\t\t<\/figure>\n\t<\/div>\n\n\n\t<p>\n\t\t<a href=\"https:\/\/lp.suno.com.br\/planilha-controle-gastos\/\" target=\"_blank\" data-element=\"shortcode-suno-banner\" title=\"Banner SUNO, clique e saiba mais\">\n\t\t\t<picture>\n\t\t\t\t<source media=\"(max-width: 500px)\" srcset=\"https:\/\/files.sunoresearch.com.br\/n\/uploads\/2023\/03\/400x300-Planilha-controle-de-gastos.png\">\n\t\t\t\t<img class=\"newsContent__article__imgCapa newsContent__article__imgCapa--banner\"\n\t\t\t\t\tsrc=\"https:\/\/files.sunoresearch.com.br\/n\/uploads\/2023\/03\/1420x240-Planilha-controle-de-gastos.png\"\n\t\t\t\t\tdata-promo-id=\"101751\"\t\t\t\t\t\t\t\t\t\twidth='1420' height='240'\t\t\t\t\talt=\"https:\/\/files.sunoresearch.com.br\/n\/uploads\/2023\/03\/1420x240-Planilha-controle-de-gastos.png\"\n\t\t\t\t>\n\t\t\t<\/picture>\n\t\t<\/a>\n\t<\/p>\n\n\n<p>Em <a class=\"suno-keyword\" href=\"https:\/\/www.suno.com.br\/artigos\/fato-relevante\/\" target=\"_blank\" rel=\"noopener\" data-force=\"no\" data-priority=\"1\">fato relevante<\/a> divulgado na quarta-feira (17), a Hypera informou que os ativos fizeram parte da negocia\u00e7\u00e3o recente entre a companhia e a <strong>Sanofi<\/strong>, comunicada <a href=\"https:\/\/www.suno.com.br\/noticias\/hypera-hype3-marcas-190-milhoes-sanofi\/\" target=\"_blank\" rel=\"noopener\">em julho aos acionistas<\/a>.<\/p>\n<p>No mais, a empresa esclarece que a venda dos ativos est\u00e1 alinhada \u00e0 estrat\u00e9gia de focar no mercado farmac\u00eautico brasileiro.<\/p>\n<p>A conclus\u00e3o da <strong>venda para a Eurofarma<\/strong> est\u00e1 sujeita a certas condi\u00e7\u00f5es precedentes, incluindo a aprova\u00e7\u00e3o pelas autoridades antitruste competentes, diz fato relevante.<\/p>\n<p>Leia mais:<\/p>\n\t<div data-element=\"shortcode-read-more\" class=\"knowMore\">\n\t\t\t\t<a class=\"knowMore__link\" href=\"https:\/\/www.suno.com.br\/noticias\/hypera-hype3-marcas-190-milhoes-sanofi\/\">\n\t\t\tHypera (HYPE3) compra 12 marcas de medicamentos da Sanofi por US$ 190 milh\u00f5es\t\t<\/a>\n\t<\/div>\n\n\n\t<p>\n\t\t<a href=\"https:\/\/lp.suno.com.br\/ebook-como-analisar-uma-acao\/\" target=\"_blank\" data-element=\"shortcode-suno-banner\" title=\"Banner SUNO, clique e saiba mais\">\n\t\t\t<picture>\n\t\t\t\t<source media=\"(max-width: 500px)\" srcset=\"https:\/\/files.sunoresearch.com.br\/n\/uploads\/2023\/03\/Ebook-Acoes-Mobile-1.jpg\">\n\t\t\t\t<img class=\"newsContent__article__imgCapa newsContent__article__imgCapa--banner\"\n\t\t\t\t\tsrc=\"https:\/\/files.sunoresearch.com.br\/n\/uploads\/2023\/03\/Ebook-Acoes-Desktop-1.jpg\"\n\t\t\t\t\tdata-promo-id=\"171998\"\t\t\t\t\t\t\t\t\t\twidth='1420' height='286'\t\t\t\t\talt=\"https:\/\/files.sunoresearch.com.br\/n\/uploads\/2023\/03\/Ebook-Acoes-Desktop-1.jpg\"\n\t\t\t\t>\n\t\t\t<\/picture>\n\t\t<\/a>\n\t<\/p>\n\n\n<h2>Lucro da Hypera no 3T21 cai 41,7%, para R$ R$ 201,6 milh\u00f5es<\/h2>\n<p>O <strong><a class=\"suno-keyword\" href=\"https:\/\/www.suno.com.br\/artigos\/lucro-liquido\/\" target=\"_blank\" rel=\"noopener\" data-force=\"no\" data-priority=\"1\">lucro l\u00edquido<\/a> da Hypera<\/strong>\u00a0no terceiro trimestre deste somou R$ 201,6 milh\u00f5es, valor 41,7% menor em compara\u00e7\u00e3o com os ganhos apurados no mesmo per\u00edodo do ano passado.<\/p>\n<p>Por outro lado, o lucro l\u00edquido das opera\u00e7\u00f5es continuadas (ajustado) da Hypera somou R$ 464,7 milh\u00f5es, avan\u00e7o anual de 32,9%. No acumulado do ano, a farmac\u00eautica registrou R$ 977,2 milh\u00f5es em lucro l\u00edquido, com leve recuo de 0,3% na mesma base de compara\u00e7\u00e3o.<\/p>\n<p>Para o Goldman Sachs, o resultado foi em linha com o esperado. O banco de investimentos aponta que houve crescimento da receita devido \u00e0 integra\u00e7\u00e3o do <strong>Buscopan<\/strong> e dos <strong>portf\u00f3lios da Takeda<\/strong>. O resultado superou em 2% a estimativa do banco.<\/p>\n\t<p>\n\t\t<a href=\"https:\/\/lp.suno.com.br\/planilha-de-controle-de-investimentos\/\" target=\"_blank\" data-element=\"shortcode-suno-banner\" title=\"Banner SUNO, clique e saiba mais\">\n\t\t\t<picture>\n\t\t\t\t<source media=\"(max-width: 500px)\" srcset=\"https:\/\/files.sunoresearch.com.br\/n\/uploads\/2023\/03\/400x300-Controle-de-Investimentos.png\">\n\t\t\t\t<img class=\"newsContent__article__imgCapa newsContent__article__imgCapa--banner\"\n\t\t\t\t\tsrc=\"https:\/\/files.sunoresearch.com.br\/n\/uploads\/2023\/03\/1420x240-Controle-de-Investimentos.png\"\n\t\t\t\t\tdata-promo-id=\"75934\"\t\t\t\t\t\t\t\t\t\twidth='1420' height='240'\t\t\t\t\talt=\"https:\/\/files.sunoresearch.com.br\/n\/uploads\/2023\/03\/1420x240-Controle-de-Investimentos.png\"\n\t\t\t\t>\n\t\t\t<\/picture>\n\t\t<\/a>\n\t<\/p>\n\n\n<p>\u201cO segmento de cuidados com a pele foi impulsionado por extens\u00f5es de linhas recentes e um forte desempenho no portf\u00f3lio adquirido de Glenmark, no in\u00edcio de 2020. Na sa\u00fade do consumidor, gastrointestinal, nutricional e medicamentos antifluorescentes ocuparam lugar de destaque no trimestre\u201d, lembra o Goldman Sachs em seu relat\u00f3rio.<\/p>\n<h2>Cota\u00e7\u00e3o nesta quinta-feira (18)<\/h2>\n<p>A cota\u00e7\u00e3o da <strong>Hypera<\/strong> apresentava alta de 1,81% \u00e0s 10:40 desta quinta. As a\u00e7\u00f5es HYPE3 eram negociadas a R$ 29,25 neste mesmo hor\u00e1rio.<\/p>\n\t<p>\n\t\t<a href=\"\" target=\"_blank\" data-element=\"shortcode-suno-banner\" title=\"Banner SUNO, clique e saiba mais\">\n\t\t\t<picture>\n\t\t\t\t<source media=\"(max-width: 500px)\" srcset=\"\">\n\t\t\t\t<img class=\"newsContent__article__imgCapa newsContent__article__imgCapa--banner\"\n\t\t\t\t\tsrc=\"\"\n\t\t\t\t\tdata-promo-id=\"184190\"\t\t\t\t\t\t\t\t\t\t\t\t\t\t\talt=\"\"\n\t\t\t\t>\n\t\t\t<\/picture>\n\t\t<\/a>\n\t<\/p>\n\n\n","protected":false},"excerpt":{"rendered":"<p>A Hypera (HYPE3) fechou contrato com a Eurofarma para a venda do portf\u00f3lio de produtos farmac\u00eauticos isentos de prescri\u00e7\u00e3o m\u00e9dica, ou seja, de venda livre, e tamb\u00e9m dos que exigem o pedido m\u00e9dico na Col\u00f4mbia e no M\u00e9xico. O valor total da opera\u00e7\u00e3o ser\u00e1 de US$ 51,6 milh\u00f5es. Hypera (HYPE3). Foto Divulga\u00e7\u00e3o Em fato relevante [&hellip;]<\/p>\n","protected":false},"author":102,"featured_media":130337,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":[],"categories":[64],"tags":[501],"suno_strategy":[],"class_list":["post-206432","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-negocios","tag-hypera-pharma-hype3"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v24.4 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Hypera (HYPE3) vende portf\u00f3lio de medicamentos para a Eurofarma<\/title>\n<meta name=\"description\" content=\"A Hypera (HYPE3) fechou contrato de venda do seu portf\u00f3lio de medicamentos para a Eurofarma. Veja detalhes da opera\u00e7\u00e3o aqui.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.suno.com.br\/noticias\/hypera-hype3-venda-eurofarma\/\" \/>\n<meta property=\"og:locale\" content=\"pt_BR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Hypera (HYPE3) vende portf\u00f3lio de medicamentos para a Eurofarma\" \/>\n<meta property=\"og:description\" content=\"A Hypera (HYPE3) fechou contrato de venda do seu portf\u00f3lio de medicamentos para a Eurofarma. Veja detalhes da opera\u00e7\u00e3o aqui.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.suno.com.br\/noticias\/hypera-hype3-venda-eurofarma\/\" \/>\n<meta property=\"og:site_name\" content=\"Suno Not\u00edcias\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/facebook.com\/sunoresearch\" \/>\n<meta property=\"og:image\" content=\"https:\/\/files.sunoresearch.com.br\/n\/uploads\/2021\/03\/a651c83b-hypera.jpg.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1200\" \/>\n\t<meta property=\"og:image:height\" content=\"800\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Monique Lima\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@sunoresearch\" \/>\n<meta name=\"twitter:site\" content=\"@sunoresearch\" \/>\n<meta name=\"twitter:label1\" content=\"Escrito por\" \/>\n\t<meta name=\"twitter:data1\" content=\"Monique Lima\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. tempo de leitura\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutos\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"NewsArticle\",\"@id\":\"https:\/\/www.suno.com.br\/noticias\/hypera-hype3-venda-eurofarma\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/www.suno.com.br\/noticias\/hypera-hype3-venda-eurofarma\/\"},\"author\":{\"name\":\"Monique Lima\",\"@id\":\"https:\/\/www.suno.com.br\/noticias\/#\/schema\/person\/d712329319cc9b10f254d02d654cb36a\"},\"headline\":\"Hypera (HYPE3) vende portf\u00f3lio de medicamentos para a Eurofarma, por US$ 51 milh\u00f5es\",\"datePublished\":\"2021-11-18T14:11:38+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/www.suno.com.br\/noticias\/hypera-hype3-venda-eurofarma\/\"},\"wordCount\":375,\"publisher\":{\"@id\":\"https:\/\/www.suno.com.br\/noticias\/#organization\"},\"image\":{\"@id\":\"https:\/\/www.suno.com.br\/noticias\/hypera-hype3-venda-eurofarma\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/files.sunoresearch.com.br\/n\/uploads\/2021\/03\/a651c83b-hypera.jpg-jpg.webp\",\"keywords\":[\"Hypera Pharma (HYPE3)\"],\"articleSection\":[\"Neg\u00f3cios\"],\"inLanguage\":\"pt-BR\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.suno.com.br\/noticias\/hypera-hype3-venda-eurofarma\/\",\"url\":\"https:\/\/www.suno.com.br\/noticias\/hypera-hype3-venda-eurofarma\/\",\"name\":\"Hypera (HYPE3) vende portf\u00f3lio de medicamentos para a Eurofarma\",\"isPartOf\":{\"@id\":\"https:\/\/www.suno.com.br\/noticias\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/www.suno.com.br\/noticias\/hypera-hype3-venda-eurofarma\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/www.suno.com.br\/noticias\/hypera-hype3-venda-eurofarma\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/files.sunoresearch.com.br\/n\/uploads\/2021\/03\/a651c83b-hypera.jpg-jpg.webp\",\"datePublished\":\"2021-11-18T14:11:38+00:00\",\"description\":\"A Hypera (HYPE3) fechou contrato de venda do seu portf\u00f3lio de medicamentos para a Eurofarma. Veja detalhes da opera\u00e7\u00e3o aqui.\",\"breadcrumb\":{\"@id\":\"https:\/\/www.suno.com.br\/noticias\/hypera-hype3-venda-eurofarma\/#breadcrumb\"},\"inLanguage\":\"pt-BR\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.suno.com.br\/noticias\/hypera-hype3-venda-eurofarma\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"pt-BR\",\"@id\":\"https:\/\/www.suno.com.br\/noticias\/hypera-hype3-venda-eurofarma\/#primaryimage\",\"url\":\"https:\/\/files.sunoresearch.com.br\/n\/uploads\/2021\/03\/a651c83b-hypera.jpg-jpg.webp\",\"contentUrl\":\"https:\/\/files.sunoresearch.com.br\/n\/uploads\/2021\/03\/a651c83b-hypera.jpg-jpg.webp\",\"width\":1200,\"height\":800,\"caption\":\"Hypera (HYPE3). Foto Divulga\u00e7\u00e3o\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.suno.com.br\/noticias\/hypera-hype3-venda-eurofarma\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Not\u00edcias\",\"item\":\"https:\/\/www.suno.com.br\/noticias\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Neg\u00f3cios\",\"item\":\"https:\/\/www.suno.com.br\/noticias\/negocios\/\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"Hypera (HYPE3) vende portf\u00f3lio de medicamentos para a Eurofarma, por US$ 51 milh\u00f5es\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.suno.com.br\/noticias\/#website\",\"url\":\"https:\/\/www.suno.com.br\/noticias\/\",\"name\":\"Suno Not\u00edcias\",\"description\":\"Seu portal de informa\u00e7\u00e3o sobre o mundo dos investimentos\",\"publisher\":{\"@id\":\"https:\/\/www.suno.com.br\/noticias\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.suno.com.br\/noticias\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"pt-BR\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/www.suno.com.br\/noticias\/#organization\",\"name\":\"Suno Not\u00edcias\",\"url\":\"https:\/\/www.suno.com.br\/noticias\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"pt-BR\",\"@id\":\"https:\/\/www.suno.com.br\/noticias\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/files.sunoresearch.com.br\/n\/uploads\/2021\/09\/suno-logo.png\",\"contentUrl\":\"https:\/\/files.sunoresearch.com.br\/n\/uploads\/2021\/09\/suno-logo.png\",\"width\":180,\"height\":180,\"caption\":\"Suno Not\u00edcias\"},\"image\":{\"@id\":\"https:\/\/www.suno.com.br\/noticias\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/facebook.com\/sunoresearch\",\"https:\/\/x.com\/sunoresearch\",\"https:\/\/www.instagram.com\/suno\",\"https:\/\/www.linkedin.com\/company\/suno-research\/\",\"https:\/\/www.youtube.com\/c\/sunoresearch\"]},{\"@type\":\"Person\",\"@id\":\"https:\/\/www.suno.com.br\/noticias\/#\/schema\/person\/d712329319cc9b10f254d02d654cb36a\",\"name\":\"Monique Lima\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"pt-BR\",\"@id\":\"https:\/\/www.suno.com.br\/noticias\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/daee7f16d906c2e9ffed236206ca2c30?s=96&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/daee7f16d906c2e9ffed236206ca2c30?s=96&r=g\",\"caption\":\"Monique Lima\"},\"description\":\"Rep\u00f3rter de Mercado no Suno Not\u00edcias, \u00e9 jornalista com experi\u00eancia na cobertura de economia, empreendedorismo, finan\u00e7as pessoais, mercado financeiro, carreira e recursos humanos. Formada em Jornalismo pela Universidade Paulista, teve experi\u00eancias em ve\u00edculos de comunica\u00e7\u00e3o como a Ag\u00eancia TradeMap, Revista Voc\u00ea S\/A e Revista Voc\u00ea RH, as duas \u00faltimas publica\u00e7\u00f5es da Editora Abril. No Suno Not\u00edcias, fala sobre as principais not\u00edcias de Fundos Imobili\u00e1rios, Fiagro, Startups e empresas listadas na Bolsa.\",\"url\":\"https:\/\/www.suno.com.br\/noticias\/author\/monique-lima\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Hypera (HYPE3) vende portf\u00f3lio de medicamentos para a Eurofarma","description":"A Hypera (HYPE3) fechou contrato de venda do seu portf\u00f3lio de medicamentos para a Eurofarma. Veja detalhes da opera\u00e7\u00e3o aqui.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.suno.com.br\/noticias\/hypera-hype3-venda-eurofarma\/","og_locale":"pt_BR","og_type":"article","og_title":"Hypera (HYPE3) vende portf\u00f3lio de medicamentos para a Eurofarma","og_description":"A Hypera (HYPE3) fechou contrato de venda do seu portf\u00f3lio de medicamentos para a Eurofarma. Veja detalhes da opera\u00e7\u00e3o aqui.","og_url":"https:\/\/www.suno.com.br\/noticias\/hypera-hype3-venda-eurofarma\/","og_site_name":"Suno Not\u00edcias","article_publisher":"https:\/\/facebook.com\/sunoresearch","og_image":[{"width":1200,"height":800,"url":"https:\/\/files.sunoresearch.com.br\/n\/uploads\/2021\/03\/a651c83b-hypera.jpg.jpg","type":"image\/jpeg"}],"author":"Monique Lima","twitter_card":"summary_large_image","twitter_creator":"@sunoresearch","twitter_site":"@sunoresearch","twitter_misc":{"Escrito por":"Monique Lima","Est. tempo de leitura":"2 minutos"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"NewsArticle","@id":"https:\/\/www.suno.com.br\/noticias\/hypera-hype3-venda-eurofarma\/#article","isPartOf":{"@id":"https:\/\/www.suno.com.br\/noticias\/hypera-hype3-venda-eurofarma\/"},"author":{"name":"Monique Lima","@id":"https:\/\/www.suno.com.br\/noticias\/#\/schema\/person\/d712329319cc9b10f254d02d654cb36a"},"headline":"Hypera (HYPE3) vende portf\u00f3lio de medicamentos para a Eurofarma, por US$ 51 milh\u00f5es","datePublished":"2021-11-18T14:11:38+00:00","mainEntityOfPage":{"@id":"https:\/\/www.suno.com.br\/noticias\/hypera-hype3-venda-eurofarma\/"},"wordCount":375,"publisher":{"@id":"https:\/\/www.suno.com.br\/noticias\/#organization"},"image":{"@id":"https:\/\/www.suno.com.br\/noticias\/hypera-hype3-venda-eurofarma\/#primaryimage"},"thumbnailUrl":"https:\/\/files.sunoresearch.com.br\/n\/uploads\/2021\/03\/a651c83b-hypera.jpg-jpg.webp","keywords":["Hypera Pharma (HYPE3)"],"articleSection":["Neg\u00f3cios"],"inLanguage":"pt-BR"},{"@type":"WebPage","@id":"https:\/\/www.suno.com.br\/noticias\/hypera-hype3-venda-eurofarma\/","url":"https:\/\/www.suno.com.br\/noticias\/hypera-hype3-venda-eurofarma\/","name":"Hypera (HYPE3) vende portf\u00f3lio de medicamentos para a Eurofarma","isPartOf":{"@id":"https:\/\/www.suno.com.br\/noticias\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.suno.com.br\/noticias\/hypera-hype3-venda-eurofarma\/#primaryimage"},"image":{"@id":"https:\/\/www.suno.com.br\/noticias\/hypera-hype3-venda-eurofarma\/#primaryimage"},"thumbnailUrl":"https:\/\/files.sunoresearch.com.br\/n\/uploads\/2021\/03\/a651c83b-hypera.jpg-jpg.webp","datePublished":"2021-11-18T14:11:38+00:00","description":"A Hypera (HYPE3) fechou contrato de venda do seu portf\u00f3lio de medicamentos para a Eurofarma. Veja detalhes da opera\u00e7\u00e3o aqui.","breadcrumb":{"@id":"https:\/\/www.suno.com.br\/noticias\/hypera-hype3-venda-eurofarma\/#breadcrumb"},"inLanguage":"pt-BR","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.suno.com.br\/noticias\/hypera-hype3-venda-eurofarma\/"]}]},{"@type":"ImageObject","inLanguage":"pt-BR","@id":"https:\/\/www.suno.com.br\/noticias\/hypera-hype3-venda-eurofarma\/#primaryimage","url":"https:\/\/files.sunoresearch.com.br\/n\/uploads\/2021\/03\/a651c83b-hypera.jpg-jpg.webp","contentUrl":"https:\/\/files.sunoresearch.com.br\/n\/uploads\/2021\/03\/a651c83b-hypera.jpg-jpg.webp","width":1200,"height":800,"caption":"Hypera (HYPE3). Foto Divulga\u00e7\u00e3o"},{"@type":"BreadcrumbList","@id":"https:\/\/www.suno.com.br\/noticias\/hypera-hype3-venda-eurofarma\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Not\u00edcias","item":"https:\/\/www.suno.com.br\/noticias\/"},{"@type":"ListItem","position":2,"name":"Neg\u00f3cios","item":"https:\/\/www.suno.com.br\/noticias\/negocios\/"},{"@type":"ListItem","position":3,"name":"Hypera (HYPE3) vende portf\u00f3lio de medicamentos para a Eurofarma, por US$ 51 milh\u00f5es"}]},{"@type":"WebSite","@id":"https:\/\/www.suno.com.br\/noticias\/#website","url":"https:\/\/www.suno.com.br\/noticias\/","name":"Suno Not\u00edcias","description":"Seu portal de informa\u00e7\u00e3o sobre o mundo dos investimentos","publisher":{"@id":"https:\/\/www.suno.com.br\/noticias\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.suno.com.br\/noticias\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"pt-BR"},{"@type":"Organization","@id":"https:\/\/www.suno.com.br\/noticias\/#organization","name":"Suno Not\u00edcias","url":"https:\/\/www.suno.com.br\/noticias\/","logo":{"@type":"ImageObject","inLanguage":"pt-BR","@id":"https:\/\/www.suno.com.br\/noticias\/#\/schema\/logo\/image\/","url":"https:\/\/files.sunoresearch.com.br\/n\/uploads\/2021\/09\/suno-logo.png","contentUrl":"https:\/\/files.sunoresearch.com.br\/n\/uploads\/2021\/09\/suno-logo.png","width":180,"height":180,"caption":"Suno Not\u00edcias"},"image":{"@id":"https:\/\/www.suno.com.br\/noticias\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/facebook.com\/sunoresearch","https:\/\/x.com\/sunoresearch","https:\/\/www.instagram.com\/suno","https:\/\/www.linkedin.com\/company\/suno-research\/","https:\/\/www.youtube.com\/c\/sunoresearch"]},{"@type":"Person","@id":"https:\/\/www.suno.com.br\/noticias\/#\/schema\/person\/d712329319cc9b10f254d02d654cb36a","name":"Monique Lima","image":{"@type":"ImageObject","inLanguage":"pt-BR","@id":"https:\/\/www.suno.com.br\/noticias\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/daee7f16d906c2e9ffed236206ca2c30?s=96&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/daee7f16d906c2e9ffed236206ca2c30?s=96&r=g","caption":"Monique Lima"},"description":"Rep\u00f3rter de Mercado no Suno Not\u00edcias, \u00e9 jornalista com experi\u00eancia na cobertura de economia, empreendedorismo, finan\u00e7as pessoais, mercado financeiro, carreira e recursos humanos. Formada em Jornalismo pela Universidade Paulista, teve experi\u00eancias em ve\u00edculos de comunica\u00e7\u00e3o como a Ag\u00eancia TradeMap, Revista Voc\u00ea S\/A e Revista Voc\u00ea RH, as duas \u00faltimas publica\u00e7\u00f5es da Editora Abril. No Suno Not\u00edcias, fala sobre as principais not\u00edcias de Fundos Imobili\u00e1rios, Fiagro, Startups e empresas listadas na Bolsa.","url":"https:\/\/www.suno.com.br\/noticias\/author\/monique-lima\/"}]}},"default_loop_html":"<div class=\"cardsPage__listCard__boxs\"><div class=\"cardsPage__listCard__boxs__img\"><a href=\"https:\/\/www.suno.com.br\/noticias\/hypera-hype3-venda-eurofarma\/\"><img class=\"mask\" src=\"https:\/\/www.suno.com.br\/noticias\/wp-content\/themes\/suno\/resources\/images\/spotlight\/spotlight1img\/bg-mask.png\" alt=\"Image Mask\"\/><img src=\"https:\/\/files.sunoresearch.com.br\/n\/uploads\/2021\/03\/a651c83b-hypera.jpg-400x200.webp\" alt=\"Hypera (HYPE3) vende portf\u00f3lio de medicamentos para a Eurofarma, por US$ 51 milh\u00f5es\"\/><\/a><span class=\"spotlightCategory\"><a href=\"https:\/\/www.suno.com.br\/noticias\/negocios\/\">Neg\u00f3cios<\/a><\/span><\/div><div class=\"cardsPage__listCard__boxs__content\"><a href=\"https:\/\/www.suno.com.br\/noticias\/hypera-hype3-venda-eurofarma\/\"><h2 class=\"content__title\">Hypera (HYPE3) vende portf\u00f3lio de medicamentos para a Eurofarma, por US$ 51 milh\u00f5es<\/h2><\/a><div class=\"newsContent__article__meta\"><div class=\"newsContent__article__meta__authorBox\"><a href=\"https:\/\/www.suno.com.br\/noticias\/author\/monique-lima\/\" class=\"authorBox__avatar noMobi\"><img src=\"https:\/\/secure.gravatar.com\/avatar\/daee7f16d906c2e9ffed236206ca2c30?s=96&#038;r=g\" alt=\"Monique Lima\"><\/a><div class=\"authorBox__name\"><span>por\n\t\t\t<a href=\"https:\/\/www.suno.com.br\/noticias\/author\/monique-lima\/\"><span itemprop=\"author\">Monique Lima<\/span><\/a><\/span><time datetime=\"2021-11-18T11:11:38-03:00\" itemprop=\"datePublished\">18\/11\/2021 11:11<\/time><\/div><\/div><\/div><\/div><\/div>","single_layout":"posts","amp_enabled":true,"_links":{"self":[{"href":"https:\/\/www.suno.com.br\/noticias\/wp-json\/wp\/v2\/posts\/206432"}],"collection":[{"href":"https:\/\/www.suno.com.br\/noticias\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.suno.com.br\/noticias\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.suno.com.br\/noticias\/wp-json\/wp\/v2\/users\/102"}],"replies":[{"embeddable":true,"href":"https:\/\/www.suno.com.br\/noticias\/wp-json\/wp\/v2\/comments?post=206432"}],"version-history":[{"count":3,"href":"https:\/\/www.suno.com.br\/noticias\/wp-json\/wp\/v2\/posts\/206432\/revisions"}],"predecessor-version":[{"id":206486,"href":"https:\/\/www.suno.com.br\/noticias\/wp-json\/wp\/v2\/posts\/206432\/revisions\/206486"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.suno.com.br\/noticias\/wp-json\/wp\/v2\/media\/130337"}],"wp:attachment":[{"href":"https:\/\/www.suno.com.br\/noticias\/wp-json\/wp\/v2\/media?parent=206432"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.suno.com.br\/noticias\/wp-json\/wp\/v2\/categories?post=206432"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.suno.com.br\/noticias\/wp-json\/wp\/v2\/tags?post=206432"},{"taxonomy":"suno_strategy","embeddable":true,"href":"https:\/\/www.suno.com.br\/noticias\/wp-json\/wp\/v2\/suno_strategy?post=206432"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}